IN191021B - - Google Patents

Info

Publication number
IN191021B
IN191021B IN672MU2001A IN191021B IN 191021 B IN191021 B IN 191021B IN 672MU2001 A IN672MU2001 A IN 672MU2001A IN 191021 B IN191021 B IN 191021B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Daniel Jasserand
Uwe Schon
Holger Sann
Reinhard Bruckner
Christian Eeckhout
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of IN191021B publication Critical patent/IN191021B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN672MU2001 2000-07-28 2001-07-16 IN191021B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10036818A DE10036818A1 (de) 2000-07-28 2000-07-28 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
IN191021B true IN191021B (cg-RX-API-DMAC7.html) 2003-09-13

Family

ID=7650544

Family Applications (1)

Application Number Title Priority Date Filing Date
IN672MU2001 IN191021B (cg-RX-API-DMAC7.html) 2000-07-28 2001-07-16

Country Status (27)

Country Link
US (1) US6407106B1 (cg-RX-API-DMAC7.html)
EP (1) EP1176144B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002053577A (cg-RX-API-DMAC7.html)
KR (1) KR100924405B1 (cg-RX-API-DMAC7.html)
CN (1) CN1167698C (cg-RX-API-DMAC7.html)
AR (1) AR028743A1 (cg-RX-API-DMAC7.html)
AT (1) ATE244716T1 (cg-RX-API-DMAC7.html)
AU (1) AU779318B2 (cg-RX-API-DMAC7.html)
BR (1) BR0103048A (cg-RX-API-DMAC7.html)
CA (1) CA2354213C (cg-RX-API-DMAC7.html)
CZ (1) CZ301695B6 (cg-RX-API-DMAC7.html)
DE (2) DE10036818A1 (cg-RX-API-DMAC7.html)
DK (1) DK1176144T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ3119A1 (cg-RX-API-DMAC7.html)
ES (1) ES2201007T3 (cg-RX-API-DMAC7.html)
HU (1) HU226687B1 (cg-RX-API-DMAC7.html)
IL (1) IL144299A (cg-RX-API-DMAC7.html)
IN (1) IN191021B (cg-RX-API-DMAC7.html)
NO (1) NO323233B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ513041A (cg-RX-API-DMAC7.html)
PL (1) PL210436B1 (cg-RX-API-DMAC7.html)
PT (1) PT1176144E (cg-RX-API-DMAC7.html)
RU (1) RU2288918C2 (cg-RX-API-DMAC7.html)
SK (1) SK284802B6 (cg-RX-API-DMAC7.html)
TW (1) TWI304403B (cg-RX-API-DMAC7.html)
UA (1) UA73728C2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200105737B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77515C2 (en) * 2002-04-04 2006-12-15 Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity
AU2003230829B8 (en) * 2002-04-26 2008-12-11 Eli Lilly And Company Triazole derivatives as tachykinin receptor antagonists
SI1501808T1 (sl) * 2002-04-26 2008-10-31 Lilly Co Eli Antagonisti tahikininskega receptorja
US20060160794A1 (en) * 2003-06-12 2006-07-20 Amegadzie Albert K Tachykinin receptor antagonists
US20070082905A1 (en) * 2005-05-27 2007-04-12 De Vries Michiel H Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using same
ES2353724T3 (es) * 2005-07-25 2011-03-04 F. Hoffmann-La Roche Ag Derivados de triazol substitutidos y su uso como antagonistas del receptor neuroquinina 3.
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
US8093268B2 (en) 2007-01-24 2012-01-10 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
EP2467159A1 (en) 2009-08-20 2012-06-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
WO2013004766A1 (en) 2011-07-04 2013-01-10 Ferrari Giulio Nk-1 receptor antagonists for treating corneal neovascularisation
RU2020131446A (ru) 2018-02-26 2022-03-28 Оспедале Сан Раффаэле С.Р.Л. Антагонисты nk-1 для применения в лечении глазной боли
EP4117673A1 (en) 2020-03-11 2023-01-18 Ospedale San Raffaele S.r.l. Treatment of stem cell deficiency
CN115184498B (zh) * 2022-07-15 2023-02-21 山东京卫制药有限公司 N-Boc-哌嗪中有关物质哌嗪的检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5883098A (en) 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
US5637592A (en) * 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
NZ307625A (en) * 1995-05-25 1999-02-25 Fujisawa Pharmaceutical Co 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
GB9513118D0 (en) * 1995-06-28 1995-08-30 Merck Sharp & Dohme Therapeutic agents
JP2000502100A (ja) * 1995-12-18 2000-02-22 藤沢薬品工業株式会社 タキキニン拮抗薬としてのピペラジン誘導体
KR100458346B1 (ko) * 1996-03-29 2005-06-21 듀파 인터내셔날 리서치 베 파우 피페라진및피페리딘화합물
AUPO735997A0 (en) * 1997-06-17 1997-07-10 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
DE19824865A1 (de) 1997-08-27 1999-03-04 Solvay Pharm Gmbh Neue Harnstoffderivate
EP0899270B1 (de) * 1997-08-27 2008-05-21 Solvay Pharmaceuticals GmbH Indolmethyl-N,N'-bisacylpiperazine als Neurokininrezeptorantagonisten
ES2162731B1 (es) * 1999-06-04 2003-02-16 Faes Fabrica Espanola De Produ Nuevas arilpiperacilnilalquil-3(2h)-piridacinonas.

Also Published As

Publication number Publication date
EP1176144B1 (de) 2003-07-09
CZ20011813A3 (cs) 2002-03-13
UA73728C2 (en) 2005-09-15
AR028743A1 (es) 2003-05-21
HU226687B1 (en) 2009-06-29
AU779318B2 (en) 2005-01-13
NO20013709D0 (no) 2001-07-27
DZ3119A1 (fr) 2004-09-19
SK284802B6 (sk) 2005-11-03
KR20020010482A (ko) 2002-02-04
DE10036818A1 (de) 2002-02-07
CA2354213A1 (en) 2002-01-28
PT1176144E (pt) 2003-11-28
KR100924405B1 (ko) 2009-10-29
US20020065276A1 (en) 2002-05-30
HU0102931D0 (en) 2001-09-28
EP1176144A1 (de) 2002-01-30
HUP0102931A3 (en) 2003-07-28
NO323233B1 (no) 2007-02-05
IL144299A0 (en) 2002-05-23
IL144299A (en) 2004-08-31
ATE244716T1 (de) 2003-07-15
JP2002053577A (ja) 2002-02-19
HUP0102931A2 (hu) 2002-11-28
PL210436B1 (pl) 2012-01-31
NZ513041A (en) 2002-12-20
BR0103048A (pt) 2002-04-02
CZ301695B6 (cs) 2010-05-26
CA2354213C (en) 2010-04-27
DE50100358D1 (de) 2003-08-14
AU5767501A (en) 2002-01-31
HK1042699A1 (en) 2002-08-23
ZA200105737B (en) 2002-01-22
US6407106B1 (en) 2002-06-18
NO20013709L (no) 2002-01-29
SK7572001A3 (en) 2002-02-05
CN1167698C (zh) 2004-09-22
RU2288918C2 (ru) 2006-12-10
TWI304403B (en) 2008-12-21
CN1335316A (zh) 2002-02-13
ES2201007T3 (es) 2004-03-16
DK1176144T3 (da) 2003-10-27
PL348946A1 (en) 2002-02-11

Similar Documents

Publication Publication Date Title
BE2014C009I2 (cg-RX-API-DMAC7.html)
BE2010C008I2 (cg-RX-API-DMAC7.html)
BE2011C032I2 (cg-RX-API-DMAC7.html)
JP2002536648A5 (cg-RX-API-DMAC7.html)
JP2003529207A5 (cg-RX-API-DMAC7.html)
JP2002537527A5 (cg-RX-API-DMAC7.html)
JP2002092625A5 (cg-RX-API-DMAC7.html)
JP2001346178A5 (cg-RX-API-DMAC7.html)
JP2001291048A5 (cg-RX-API-DMAC7.html)
JP2002057989A5 (cg-RX-API-DMAC7.html)
JP2001298358A5 (cg-RX-API-DMAC7.html)
JP2002109457A5 (cg-RX-API-DMAC7.html)
JP2002050689A5 (cg-RX-API-DMAC7.html)
CN300955183S (zh) 连接件
FR2788569A3 (cg-RX-API-DMAC7.html)
BR122012015772A2 (cg-RX-API-DMAC7.html)
CN3133324S (cg-RX-API-DMAC7.html)
CN3135584S (cg-RX-API-DMAC7.html)
CN3135921S (cg-RX-API-DMAC7.html)
CN3134893S (cg-RX-API-DMAC7.html)
CN3139603S (cg-RX-API-DMAC7.html)
CN3142239S (cg-RX-API-DMAC7.html)
BY6855C1 (cg-RX-API-DMAC7.html)
BY4905C1 (cg-RX-API-DMAC7.html)
CN3134543S (cg-RX-API-DMAC7.html)